Alzheimer's Disease and Parkinson's Disease
Open accessThe DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Abstract
Although most cases of Alzheimer's and Parkinson's disease are sporadic, some cases are clearly familial. This review, part of the Genomic Medicine series, examines the genetics of these familial forms. Although the inherited forms are rare, the knowledge derived from investigating their pathobiology has improved our understanding of the pathobiology of the more common, sporadic forms of the diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In general terms, neurodegenerative diseases are thought to be driven by the accumulation of neurotoxic material such as amyloid beta (Aβ) or myelin debris in the central nervous system (CNS) (Nussbaum and Ellis, 2003; Trapp and Nave, 2008).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Nussbaum and Ellis, 2003
In the citing paper
“PD pathology is mainly characterized by loss of neurons from the substantia nigra pars compacta in association with the accumulation of ubiquitinated alpha synuclein and other proteins in cytoplasmic inclusions (Lewy bodies) and thread-like proteinaceous inclusions within neurites (Lewy neuritis).”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [4]
In the citing paper
“However, Lewy bodies are also seen in the cerebral cortex, brainstem nuclei, limbic system, sympathetic ganglia, nucleus basalis of Meinert and myenteric plexus [4].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [4]
In the citing paper
“This review is focused on the potential of herbal medicine in AD since it is responsible for more than two-thirds of all dementia cases [5,6].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [6]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · cited 4×
“Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.”
BackgroundInfluentialSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Self-citationMutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Research works printed but not linked: 5
- 10.1001/archinte.151.5.989 · doi:10.1001/archinte.151.5.989 · Paper page
- Clark CM, Ewbank D, Lee VM-Y, Trojanowski JQ. Molecular pathology of Alzheimer's disease: neuronal cytoskeletal abnormalities. In: Growdon JH, Rossor MN, eds. The dementias. Vol. 19 of Blue books of practical neurology. Boston: Butterworth–Heinemann, 1998:285-304.
- Duvoisin RC, 1996, Adv Neurol, 69, 33
- Louis ED, 1996, Adv Neurol, 69, 311
- Matsumine H, 1997, Am J Hum Genet, 60, 588
Cited by
Items 701–800 of 1,000
Hajare, S., & Kulkarni, Y. A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149975 · Cited by 19
Yang, R., Sun, M., Chen, W. L., Feng, H., Chen, B., Liu, Y., He, Q., Wang, L., Zou, C., Luo, X., et al. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.125703 · Cited by 20
Banik, A., Amaradhi, R., Lee, D. D., Sau, M., Wang, W., Dingledine, R. J., & Ganesh, T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02297-7 · Cited by 19
Detection of Cd2+ and Pb2+ using amyloid oligomer–reduced graphene oxide composite
Kim, C., Park, J., Kim, W., Lee, W., Na, S., & Park, J. (2022) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2022.108214 · Cited by 20
Lee, B.-C., An, J., Kim, J., & Lai, E. C. (2022) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2022.3226368 · Cited by 19
Chapter 4 Functional neuroimaging of cognition
Perani, D. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88004-3 · Cited by 21
Subramaniam, R. M., Frey, K. A., Hunt, C. H., Mercier, G., Sólnes, L. B., Colletti, P. M., Lü, Y., Savir-Baruch, B., & Williams, H. T. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001815 · Cited by 18
Sertbaş, M., & Ülgen, K. Ö. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0088 · Cited by 19
Raza, M. A., Fatima, K., Saqib, Z., Maurin, J. K., & Budzianowski, A. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.06.021 · Cited by 18
Modulating Metals As A Therapeutic Strategy For Alzheimer’s Disease
Hung, L. W., & Barnham, K. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.32 · Cited by 20
Xu, Z., Wang, W.-F., Liang, X., Liu, Z., Liu, Y., Liang, L., & Zhu, X. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0438-9 · Cited by 18
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
Spitzer, P., Schieb, H., Kamrowski‐Kruck, H., Otto, M., Chiasserini, D., Parnetti, L., Herukka, S., Schuchhardt, J., Wiltfang, J., & Klafki, H. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/739847 · Cited by 21
Pan, J., Mason, N. S., Debnath, M. L., Mathis, C. A., Klunk, W. E., & Lin, K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.068 · Cited by 18
Active Aging for Individuals with Parkinson’s Disease: Definitions, Literature Review, and Models
Fereshtehnejad, S., & Lökk, J. (2014) · Parkinson s Disease · doi:10.1155/2014/739718 · Cited by 23
Gao, C., Wu, Q. J., Sun, J.-X., Song, X., Wang, J., Xiong, C., & Teng, F. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.215261 · Cited by 18
“Furthermore, changes in the sAPPα, sAPPβ, and 6E10 (Figure 5A and B) proteins were detected, which are involved in Aβ synthesis and degradation in AD-TG mice (Nussbaum and Ellis, 2003).”
BackgroundModels of Parkinson's Disease Patient Gait
Hughes, J. A., Houghten, S. K., & Brown, J. A. (2019) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2961808 · Cited by 18
Parkin Attenuates Wild-Type τ Modification in the Presence of β-Amyloid and α-Synuclein
Moussa, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9099-x · Cited by 20
Peng, W., Xie, Y., Liao, C., Bai, Y., Wang, H., & Li, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.966153 · Cited by 17
“Mutations of the essential components of the γ secretase complex presenilin 1 (PS1), presenilin 2 (PS2) gene, and of the amyloid precursor protein (APP) gene, have been identified as important familial AD-causing mutations (Campion et al., 1999; Nussbaum and Ellis, 2003).”
BackgroundSoleymani, S. M., Assarzadegan, F., Habibi, S. A. H., Mahboubi, A., & Esmaily, H. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107051 · Cited by 20
Buck, P. O., Trautman, H., & Clark, J. C. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.489725 · Cited by 17
“PD is the second most common neurodegenerative disorder behind Alzheimer’s disease (de Lau & Breteler, 2006; Nussbaum & Ellis, 2003).”
BackgroundInfluentialTreatment Patterns in Patients with Incident Parkinson’s Disease in the United States
Houghton, R., Boess, F., Verselis, L. M., Ding, Y., Freitas, R., Constantinovici, N., & Ong, R. C.-Y. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191636 · Cited by 17
“Parkinson’s disease (PD) is a neurodegenerative disorder affecting approximately one in 100 people over the age of 60 [1, 2].”
BackgroundGoh, G. S.-H., Zeng, G. J., Tay, D. K. J., Lo, N.-N., Yeo, S.-J., & Liow, M. H. L. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.11.016 · Cited by 17
Park, J. H., & Whang, W. K. (2020) · Molecules · doi:10.3390/molecules25245867 · Cited by 18
Xiang, J., Xiang, C., Zhou, L., Sun, M., Feng, L., Liu, C., Cai, L., & Gong, P. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01911 · Cited by 17
Agoriwo, M. W., Muckelt, P. E., Yeboah, C. O., Sankah, B. E. A., Agyapong‐Badu, S., Akpalu, A. K., & Stokes, M. J. (2022) · Ghana Medical Journal · doi:10.4314/gmj.v56i2.4 · Cited by 19
Park, H., Yoo, J.-S., Kim, J., Hwang, B. Y., Han, J., Yeon, S.-W., & Kang, J. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.01.008 · Cited by 19
“…disease (AD), the most common neurodegenertive disease, is characterized by irreversible neuronal loss articularly in the cortex and hippocampus, which leads o progressive impairment of memory, judgment, decision- aking, orientation to physical surroundings, and language Nussbaum and Ellis, 2003).”
BackgroundHuang, H.-J., Lee, C.-C., & Chen, C. Y. (2014) · BioMed Research International · doi:10.1155/2014/764946 · Cited by 17
Isoindol-1,3-dione and isoindol-1-one derivatives with high binding affinity to β-amyloid fibrils
Lee, H. J., Lim, S. J., Oh, S. J., Moon, D. H., Kim, D. J., Tae, J., & Yoo, K. H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.066 · Cited by 17
Masseroli, M. (2007) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2006.884367 · Cited by 19
Soft Matrix–Assisted Laser Desorption/Ionization for Labile Glycoconjugates
Lee, C., & Ni, C. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02208-4 · Cited by 17
Nasrollahi-Shirazi, S., Szöllősi, D., Yang, Q., Muratspahić, E., El‐Kasaby, A., Sučić, S., Stockner, T., Nanoff, C., & Freissmuth, M. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.000003 · Cited by 17
Li, W., Zhou, Y., Tang, G., Wong, N.-K., Yang, M., Tan, D., & Xiao, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00325 · Cited by 17
Aras, B., Seyyar, G. K., Fidan, Ö., & Çolak, E. (2021) · EXPLORE · doi:10.1016/j.explore.2021.12.002 · Cited by 16
Proteostasis defects: Medicinal challenges of imperfect aging & neurodegeneration
Kumar, P., Choudhary, A., Kinger, S., Jagtap, Y. A., Dubey, A. R., Gutti, R. K., Chitkara, D., Suresh, A. K., & Mishra, A. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.09.001 · Cited by 17
Awasthi, A., Maparu, K., & Singh, S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01672-7 · Cited by 17
Alzheimer’s Disease: Current Trends in Wales
Opeyemi, J. A. G. (2014) · Oman Medical Journal · doi:10.5001/omj.2014.73 · Cited by 16
Panda, P. K., Patil, A. S., Patel, P., & Panchal, H. (2016) · Genomics Data · doi:10.1016/j.gdata.2016.01.003 · Cited by 16
Huang, Y., Yeh, C. C., Chou, Y. C., Hu, C., Cherng, Y. G., Shih, C. C., Chen, T. L., & Liao, C. C. (2019) · QJM · doi:10.1093/qjmed/hcz015 · Cited by 18
A hemicyanine based fluorescence turn-on sensor for amyloid fibril detection in the far-red region
Warerkar, O. D., Mudliar, N. H., & Singh, P. K. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.115322 · Cited by 17
The Genetics of Alzheimer’s Disease and Parkinson’s Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_21 · Cited by 20
“A definitive diagnosis of AD requires not only the presence of severe dementia in life but also postmortem confirmation, with the presence of two histopathological features: neurofibrillary tangles and amyloid plaques (Braak and Braak, 1997; Goedert and Spillantini, 2006; Nussbaum and Ellis, 2003).”
BackgroundIntrarater Reliability of the Action Research Arm Test for Individuals with Parkinson’s Disease
Song, C.-S. (2012) · Journal of Physical Therapy Science · doi:10.1589/jpts.24.1355 · Cited by 16
Gefenaitė, G., Björk, J., Iwarsson, S., Slaug, B., Schmidt, S., & Nilsson, M. H. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01574-z · Cited by 17
“Among people 60 years and older, its prevalence is estimated at about 1%, with an age-related increase [2].”
BackgroundLi, L., Lin, H.-X., Hua, P., Yan, L., Dong, H., Tan, L., & Liu, W. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.520934 · Cited by 16
“Parkinson’s disease (PD) is a common neurodegenerative disorder affecting more than 1% of the population over 60 years old (1).”
BackgroundEtiopatogenia da Doença de Parkinson
Teive, H. A. (2019) · Revista Neurociências · doi:10.34024/rnc.2005.v13.8794 · Cited by 42
Use of antiparkinson medications among elderly Medicare beneficiaries with Parkinson's disease
Wei, Y. J., Stuart, B., & Zuckerman, I. H. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2010.07.002 · Cited by 17
Zhang, Z., Sohgawa, M., Yamashita, K., & Noda, M. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.03.025 · Cited by 16
Mitochondrial-Associated Membranes in Parkinson’s Disease
Hattori, N., Arano, T., Hatano, T., Mori, A., & Imai, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_12 · Cited by 21
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Ribarič, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084358 · Cited by 18
“The hallmark of PD is the loss of dopaminergic neurons in the SNpc, accompanied by LBs in surviving brain neurons [3,4].”
BackgroundTharmabalan, R. T., Rusli, S. ‘., Lo, R., Saidin, N. F. B., & Basar, Z. (2025) · Journal of Ethnic Foods · doi:10.1186/s42779-025-00278-2 · Cited by 23
“Furthermore, the preservation of specific foods such as fruits, rice, grains, and beans is intended to provide families with balanced nutrition [71].”
Xiao, R., Miller, J. A., Lubelski, D., Mroz, T. E., Benzel, E. C., Krishnaney, A. A., & Machado, A. G. (2017) · Neurosurgery · doi:10.1093/neuros/nyw043 · Cited by 15
Silva, P., & Vauzour, D. (2018) · Beverages · doi:10.3390/beverages4040096 · Cited by 15
“The precise cause of the neuronal degeneration underlying these disorders remains however elusive, although it is thought that several cellular and molecular events are involved in its progression, including oxidative stress increase, mitochondria function impairment, neuronal apoptosis activation, aggregated proteins…”
BackgroundKahn, L. W., Mathkour, M., Lee, S. X., Gouveia, E. E., Hanna, J. A., Garces, J., Scullen, T. A., McCormack, E., Riffle, J., Glynn, R. M., et al. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.02.018 · Cited by 15
Biglari, N., Mehdizadeh, A., Mastanabad, M. V., Gharaeikhezri, M. H., Afrakoti, L. G. M. P., Pourbala, H., Yousefi, M., & Soltani‐Zangbar, M. S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154541 · Cited by 15
Behavioral Genetic Investigations of Cognitive Aging
Finkel, D., & Reynolds, C. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-76727-7_7 · Cited by 18
Dai, D., Tropea, T. F., Robinson, J. L., Suh, E. R., Hurtig, H. I., Weintraub, D. A., Deerlin, V. M. V., Lee, E. B., Trojanowski, J. Q., & Chen‐Plotkin, A. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02199-7 · Cited by 17
CD33 rs3865444 as a risk factor for Parkinson’s disease
Siokas, V., Arseniou, S., Aloizou, A., Tsouris, Z., Liampas, I., Sgantzos, M. N., Liakos, P., Bogdanos, D. P., Hadjigeorgiou, G. M., & Dardiotis, E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135709 · Cited by 16
Apolipoprotein E Genotypes in Mexican Patients with Parkinson's Disease
Gallegos‐Arreola, M. P., Figuera, L. E., Ortiz, G. G., Jiménez-Gil, F. J., Ramírez-Vega, J., Ruíz‐Sandoval, J. L., Puebla‐Pérez, A. M., Troyo‐Sanromán, R., García‐Ortíz, J. E., Sánchez‐Corona, J., et al. (2009) · Disease Markers · doi:10.1155/2009/617863 · Cited by 15
Huang, H.-J., Chen, H., Lee, C.-C., & Chen, C. Y. (2014) · BioMed Research International · doi:10.1155/2014/452625 · Cited by 15
Rodrigo Valenzuela, B., Karla Bascuñan, G., Alfonso Valenzuela, B., & Rodrigo Chamorro, M. (2009) · Revista chilena de nutrición · doi:10.4067/s0717-75182009000400009 · Cited by 22
Precipitation-free high-affinity multivalent binding by inline lectin ligands
Rohse, P., Weickert, S., Drescher, M., & Wittmann, V. (2020) · Chemical Science · doi:10.1039/d0sc01744b · Cited by 15
Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease
Grünblatt, E. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.12.1865 · Cited by 18
Genetic Competencies Essential for Health Care Professionals in Primary Care
Engstrom, J. L., Sefton, M. G. S., Matheson, J. K., & Healy, K. M. (2005) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2005.02.002 · Cited by 15
Bonelli, R. M., Hofmann, P., Aschoff, A., Niederwieser, G., Heuberger, C., Jirikowski, G., & Kapfhammer, H. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200505000-00004 · Cited by 18
“This might be related to the incidence of AD in females being significantly higher than in males (Nussbaum and Ellis, 2003).”
BackgroundHandwriting as a Marker for PD Progression: A Shift in Paradigm
Pinto, S., & Velay, J. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.29 · Cited by 15
Selenium mitigates ferroptosis-mediated dopaminergic cell death by regulating the Nrf2/GPX4 pathway
Jung, Y. J., Choi, H., & Oh, E. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137314 · Cited by 14
Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia
Hu, Y. S., Ma, T. C., Alberico, S. L., Ding, Y., Jin, L., & Kang, U. J. (2023) · Movement Disorders · doi:10.1002/mds.29558 · Cited by 15
Eguchi, K., Yaguchi, H., Uwatoko, H., Iida, Y., Hamada, S., Honma, S., Takei, A., Moriwaka, F., & Yabe, I. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123158 · Cited by 14
Belding, J. N., Bonkowski, J. F., Englert, R. M., Stanfill, A. G., & Tsao, J. W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1442715 · Cited by 14
Freezing of gait in Parkinson’s disease: Classification using computational intelligence
Beigi, O. M., Nóbrega, L. R., Houghten, S. K., Pereira, A. A., & Andrade, A. D. O. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.105006 · Cited by 14
Zingipain, a Ginger Protease with Acetylcholinesterase Inhibitory Activity
Rungsaeng, P., Sangvanich, P., & Karnchanatat, A. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-013-0243-x · Cited by 14
Mo, M., Huang, W. Y., Sun, C., Zhang, L., Cen, L., Xiao, Y., Li, G.-F., Yang, X., Qu, S., & Xu, P. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.180513 · Cited by 16
“The PSMB9-TAP1-PSMB8-TAP2 haplotype (AA-G-C-AGATC) was also found to be a slight association with PD, but no significance after the Bonferroni correction.”
BackgroundInfluentialFunctional Status of Elderly Nursing Home Residents With Parkinson’s Disease
Chekani, F., Bali, V., & Aparasu, R. R. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160822 · Cited by 14
Tinelli, M., Kanavos, P. G., & Grimaccia, F. (2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 47
Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 15
Dopaminergic Neurons in Parkinson’s Disease
Prediger, R. D., Bortolanza, M., Issy, A. C., dos Santos, B. L., Bel, E. A. D., & Raisman‐Vozari, R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_7 · Cited by 16
ICU management of patients with Parkinson's disease or Parkinsonism
Freeman, W. D., Tan, K. M., Glass, G. A., Linos, K. D., Foot, C. L., & Ziegenfuss, M. D. (2007) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2007.09.007 · Cited by 14
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes
Politis, M., Roussakis, & Piccini, P. P. (2013) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19807 · Cited by 22
De novo tetrahydrobiopterin biosynthesis is impaired in the inflammed striatum of parkin(−/−) mice
Martins, R. D. P., Glaser, V., Aguiar, A. S., Ferreira, P. M. D. P., Ghisoni, K., Scheffer, D. D. L., Lanfumey, L., Raisman‐Vozari, R., Corti, O., Paul, A. L. D., et al. (2018) · Cell Biology International · doi:10.1002/cbin.10969 · Cited by 14
Genetics of Neurodegenerative Disorders
Caruso, C., Franceschi, C., & Licastro, F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307103490219 · Cited by 14
Acar, N., Parlak, H., Özkan, A., Soylu, H., Avcı, S., Üstünel, İ., Izgut-Uysal, V. N., & Ağar, A. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.12.002 · Cited by 14
Weaver, K. E., Goldman, J. G., Ribbens, N., Rasmussen, H. E., Gustashaw, K. A. R., & Tangney, C. (2019) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2019.1683116 · Cited by 14
“All participants completed the following online assessments: (1) the VioScreen FFQ at their initial visit, (2) MEPA-III screener three to seven days later, and (3) exit questionnaires in which participants evaluated the FFQ and the screener immediately following MEPA-III.”
BackgroundMethodGupta, R. V., & Kumar, P. (2021) · ACS Omega · doi:10.1021/acsomega.1c05827 · Cited by 20
Rajeshkumar, R. R., Kumar, B. K., Pavadai, P., Theivendren, P., Sundar, K., Ammunje, D. N., Pandian, S. R. K., Murugesan, S., Kabilan, S. J., & Kunjiappan, S. (2022) · Bioimpacts · doi:10.34172/bi.2022.24113 · Cited by 13
Kumar, S. A., & Sasikala, S. (2023) · Iranian Journal of Science and Technology Transactions of Electrical Engineering · doi:10.1007/s40998-023-00622-9 · Cited by 14
Intestinal Barrier Function and Neurodegenerative Disease
Wu, S., Yang, L., Fu, Y., Liao, Z., Cai, D., & Liu, Z. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273264097231116103948 · Cited by 15
Remythologizing culture: Narrativity, justification, and the politics of personalization
Quackenbush, S. W. (2004) · Journal of Clinical Psychology · doi:10.1002/jclp.20091 · Cited by 13
“Carl Rogers (1957) once suggested that empathic understanding, genuineness, and unconditional positive regard can be considered as necessary and sufficient conditions for personality change in a therapeutic context.”
BackgroundNeurologic Diseases in Special Care Patients
Robbins, M. R. (2016) · Dental Clinics of North America · doi:10.1016/j.cden.2016.03.002 · Cited by 15
In Silico Studies Applied to Natural Products with Potential Activity Against Alzheimer’s Disease
Scotti, L., & Scotti, L. (2017) · Neuromethods · doi:10.1007/978-1-4939-7404-7_18 · Cited by 14
A data driven approach reveals disease similarity on a molecular level
Lakiotaki, K., Georgakopoulos, G., Castanas, E., Røe, O. D., Borboudakis, G., & Tsamardinos, I. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0117-0 · Cited by 13
Ahyayauch, H., García‐Arribas, A. B., Masserini, M., Pantano, S., Goñi, F. M., & Alonso, A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.165 · Cited by 13
Guo, X., Tang, P., Li, X., Li, C., Zhang, X., & Li, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.996641 · Cited by 16
“Due to the hypothesis that PD and AD may share some common pathological features [30], studies had also been conducted to evaluate the association between these two A2M polymorphisms and PD, but the results were not consistent.”
ResultCognitive Function, Aging, and Ethical Decisions: Recognizing Change
Yellowitz, J. A. (2005) · Dental Clinics of North America · doi:10.1016/j.cden.2004.10.010 · Cited by 13
“neurodegenerative diseases, such as Pick’s disease and diffuse Lewy body dementia, making up most of the remaining cases [36,39].”
BackgroundInitial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited
Laurencin, C., Danaila, T., Broussolle, E., & Thobois, S. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.007 · Cited by 13
Purvis, T. E., Lubelski, D., & Mroz, T. E. (2017) · Brain Sciences · doi:10.3390/brainsci7040039 · Cited by 13
Wine-Derived Phenolic Metabolites in the Digestive and Brain Function
Zorraquín‐Peña, I., Esteban‐Fernández, A., de Llano, D. G., Bartolomé, B., & Moreno-Arribas, M. V. (2019) · Beverages · doi:10.3390/beverages5010007 · Cited by 16
“For instance, Alzheimer’s disease (AD) is responsible for two out of three cases of dementia, followed by Parkinson’s disease (PD) which is the second-most common neurodegenerative disorder affecting the global population [68].”
BackgroundImmunological and immunogenetic markers in sporadic Alzheimer’s disease
Lio, D., Scola, L., Romano, G. C., Candore, G., & Caruso, C. (2006) · Aging Clinical and Experimental Research · doi:10.1007/bf03327434 · Cited by 14
Wu, M., Li†, Y., Ji, C., Xu, J., Zheng, H., Zou, X., Gu, S., Lou, Y., Xie, Y., & Mao, Y. (2004) · DNA sequence · doi:10.1080/10425170310001656756 · Cited by 13
“Keywords: cDNA cloning; PDLIM5; BCL domain; AD7c-NTP; RT-PCR Alzheimer’s disease (AD), as the most common neurodegenerative disease, constitutes about twothirds of all cases of dementia (Nussbaum and Ellis, 2003).”
Backgroundα-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Olari, L., Liu, S., Arnold, F., Kühlwein, J., Miró, M. G., Updahaya, A. R., Stürzel, C. M., Thal, D. R., Walther, P., Sparrer, K. M. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56099-z · Cited by 12
Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders
Liska, M. G., Crowley, M. G., Lippert, T., Corey, S., & Borlongan, C. V. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_7 · Cited by 12
“These three disorders share a common motif of progressive neurodegeneration, and inefficient synaptic communicate due to neuronal death and/or aberrant protein aggregation (Nussbaum and Ellis 2003).”
BackgroundSharma, A., Kaut, O., Pavlova, A. V., Fröhlich, H., Ahmad, A., Schmitt, I., El‐Maarri, O., Oldenburg, J., & Wüllner, U. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.021 · Cited by 13
Metadata
- Authors
- Nussbaum, R. L., & Ellis, C. E.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Nussbaum, Robert L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1356-1364
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2149522871
- Cited by
- 1,351
- References
- 107
- Citations by year
- 2026: 25 · 2025: 55 · 2024: 75 · 2023: 74 · 2022: 80 · 2021: 82 · 2020: 80 · 2019: 83 · 2018: 74 · 2017: 74 · 2016: 63 · 2015: 54 · 2014: 65 · 2013: 46 · 2012: 66
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, Parkinson's disease, genetic susceptibility, inherited neurodegenerative disorders
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Humans, Molecular Sequence Data, Nerve Tissue Proteins, Substantia Nigra, Prevalence, Amyloid beta-Protein Precursor, Lewy Bodies, Mutation, Missense, Parkinsonian Disorders, Synucleins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.